ST. LOUIS, Oct. 18 /PRNewswire/ -- Monsanto Company, a subsidiary of Pharmacia Corporation (NYSE: PHA), today announced that its initial public offering of 35 million shares of common stock was priced at $20 per share. All of the shares, which will be traded on the New York Stock Exchange under the ticker symbol MON, were offered by Monsanto. Goldman, Sachs & Co. is acting as the book running lead manager for the offering. Salomon Smith Barney is acting as the joint lead manager. J.P. Morgan & Co., Morgan Stanley Dean Witter, Bear, Stearns & Co. Inc., and Merrill Lynch & Co. are co-managers for the offering. Monsanto has granted the underwriters a 30-day option to purchase up to an additional 5,250,000 shares of common stock to cover over-allotments, if any. Copies of the final prospectus relating to the offer may be obtained from Goldman, Sachs & Co. at 85 Broad Street, New York, NY 10004, 212-902-1000. Monsanto Company provides integrated, technology-based agricultural solutions for growers and downstream customers in agricultural markets. The company's corporate headquarters are located in St. Louis. Following completion of the offering, Pharmacia Corporation will continue to own more than 84 percent of Monsanto's common stock. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
SOURCE Monsanto Company